DD
Dinyar Dhun Elavia
About Dinyar Dhun Elavia
Dinyar Dhun Elavia has 18 years in corporate governance. Holds Nominee Director role. Currently with 2 companies, including Vnurture Healthcare Software Solutions Private Limited and Trust Chemists And Druggists Private Limited. Formerly with 1 company, such as Indeus Life Sciences Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Vnurture Healthcare Software Solutions Private Limited
U72900KA2007PTC158284
|
Nominee Director | 06 Jul 2010 | 2007 | Active |
Trust Chemists And Druggists Private Limited
U51397KA2003PTC031802
|
Nominee Director | 07 Dec 2023 | 2003 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Indeus Life Sciences Private Limited
U24232MH2007PTC168501
|
Director | 26 May 2008 | 2007 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dinyar Dhun Elavia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dinyar Dhun Elavia
Dinyar Dhun Elavia has 18 years in corporate governance. Holds Nominee Director role. Currently with 2 companies, including Vnurture Healthcare Software Solutions Private Limited and Trust Chemists And Druggists Private Limited. Formerly with 1 company, such as Indeus Life Sciences Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Dinyar Dhun Elavia is associated with 2 companies as Nominee Director.
Dinyar Dhun Elavia has expertise in Healthcare, General Business.
Dinyar Dhun Elavia has 18 years in corporate governance.